文献速递慢性静脉疾病

激光与射频消融大隐静脉后的耐久性结局差异

Delineating the durability outcome differences after saphenous ablation with laser versus radiofrequency.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2019-01-01

回顾性分析270例患者343条肢体,比较EVLA与RFA治疗大隐静脉功能不全的耐久性结局。两组临床症状复发率相似,但RFA组治疗部位再通率显著更高,提示解剖复发模式存在差异。

要点

  • EVLA与RFA的临床症状复发率无显著差异。
  • RFA组治疗部位再通率显著高于EVLA组。
  • 复发 reflux 最常见于大腿段。

核心结论

  • EVLA与RFA治疗大隐静脉功能不全的长期临床复发率相似,但解剖复发模式不同,RFA组治疗部位再通更常见。

研究设计与样本

  • 回顾性综述纳入2013年7月至2016年10月间接受EVLA或RFA的270例连续患者,共343条肢体。

主要发现

  • EVLA组246条肢体(183例患者),RFA组97条肢体(87例患者)。
  • 平均随访时间EVLA为112天(范围2-1153天),RFA为106天(范围3-735天;P = .786)。
  • EVLA组症状复发平均时间比RFA组长219天(EVLA n=8,均值774天,范围187-1042天;RFA n=4,均值555天,范围341-616天)。
  • 1年和3年免于临床复发的Kaplan-Meier估计值EVLA为100%和96%,RFA为97%和93%,两组无差异(log rank,P = .0666)。
  • 同部位再通率EVLA显著低于RFA(0.82% vs 2.06%;P = .0388)。

临床怎么用

  • 选择EVLA或RFA时需考虑解剖复发模式的差异,RFA术后应更关注治疗部位再通。

局限性

  • 回顾性研究设计,随访时间较短且范围变异大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The mechanism of delivering thermal energy to the vein wall differs between endovenous laser ablation (EVLA) and radiofrequency ablation (RFA). Different mechanisms of ablation may have different effects on the durability of these procedures typically performed for saphenous vein insufficiency. Whether there is a difference in long-term durability outcomes between these two techniques remains uncertain. This study aimed to delineate the durability outcome differences in terms of recurrence rate and pattern. METHODS: A retrospective review identified 270 consecutive patients who underwent saphenous ablation using EVLA or RFA between July 2013 and October 2016. The primary end points were clinical symptom recurrence and anatomic recurrence of reflux. RESULTS: Overall, 343 limbs were included in the study; 246 limbs (183 patients) underwent EVLA and 97 limbs (87 patients) underwent RFA. The mean follow-up time was 112 days for EVLA (range, 2-1153 days) and 106 days for RFA (range, 3-735 days; P = .786). No significant differences were observed between the groups with respect to demographic data, Clinical, Etiological, Anatomical, Pathophysiological classification, or ratio of great saphenous vein to small saphenous vein treated. The mean time to recurrence of symptoms was 219 days longer with EVLA (n = 8; mean, 774 days; range, 187-1042 days) than RFA (n = 4; mean 555 days; range, 341-616 days). Kaplan-Meier estimates for 1- and 3-year freedom from clinical recurrence were 100% and 96% for EVLA and 97% and 93% for RFA, respectively. There was no difference between the two groups (log rank, P = .0666). In cases with recurrent reflux documented on duplex (four in the EVLA group and three in the RFA group), the thigh segment was the most frequently involved site (75% in EVLA, 67% in RFA). Same site recanalization was significantly less frequent in EVLA (0.82% in EVLA vs 2.06% in RFA; P = .0388). New areas of reflux developed at a similar rate between the groups, in 0.82% of EVLA limbs in the anterior accessory saphenous vein and the calf great saphenous vein, and in 1.03% of RFA limbs in the anterior accessory saphenous vein (P = .8436). CONCLUSIONS: The results of our study suggest that the outcomes of EVLA and RFA performed for saphenous vein insufficiency may differ in the long term. The clinical recurrence rates are similar, but the anatomic recurrence patterns may differ, with more frequent treated site recurrence in the RFA group.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Yoon WJ, Dresher M, Crisostomo PR, et al. Delineating the durability outcome differences after saphenous ablation with laser versus radiofrequency. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31203857. doi:10.1016/j.jvsv.2018.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。